Keel
Sleep & Circadian

DSIP (Delta Sleep-Inducing Peptide)

DSIP, short for Delta Sleep-Inducing Peptide, is a naturally occurring peptide first identified in the brain tissue of animals during deep sleep. It's one of the earliest peptides ever studied for a specific link to sleep, though researchers still don't fully understand how it works.

Sequence
9 amino acids
Format
Lyophilized powder
Half-Life
Not well established; published data is limited

What Is DSIP?

DSIP was first isolated in the 1970s from the brain tissue of rabbits during a state of deep, slow-wave sleep, which is where its name comes from. It was notable at the time for being one of the first substances ever pulled directly from brain tissue specifically because of an observed connection to sleep.

Despite decades of research since then, DSIP's exact receptor and mechanism are still not fully mapped out. It's generally studied as a neuromodulator, meaning something that influences how brain signaling happens, rather than as a direct sedative that shuts activity down the way some sleep medications do.

What DSIP Is Being Researched For

  • Sleep Regulation

    The original and most consistent research focus on DSIP has been its relationship to slow-wave (delta) sleep, the deep stage of sleep associated with the most restorative rest.[1]

  • Sleep Quality in Human Studies

    A handful of human studies have looked at DSIP's effect on measures like sleep efficiency and how long it takes to fall asleep, though results across these studies have been mixed.[2]

  • Neuroendocrine Signaling

    Beyond sleep specifically, DSIP has been studied for a broader role in the body's neuroendocrine system, the network connecting the brain to hormone regulation.

How DSIP Works

  • Influencing Sleep-Related Brain Activity

    Research points to DSIP affecting the pattern of electrical activity in the brain associated with deep sleep, specifically the slow, high-amplitude waves that define that stage. Early studies found that injecting DSIP into the brain increased this specific type of activity.[1]

  • An Inconsistent Effect Depending on Timing

    One notable pattern in the research is that DSIP doesn't behave like a simple sedative. Depending on the dose and timing, some studies have reported it promoting sleep-related activity, while others have found it associated with increased alertness instead. Researchers have taken this to mean DSIP may work more by helping regulate the sleep-wake cycle than by directly inducing sleep.

Reconstitution and Handling

DSIP is typically supplied as a lyophilized powder in a sealed vial and reconstituted with bacteriostatic water before use in a research setting. Water should be added slowly rather than injected directly into the powder, and the vial should be swirled, not shaken.

Since the amount of water used affects the concentration of the final solution, researchers often use a dosage calculator to work this out before mixing. Once reconstituted, the solution is kept refrigerated to help preserve its stability.

Key Takeaways

DSIP is notable for being one of the first peptides ever isolated specifically for its connection to sleep, but more than four decades of research still hasn't fully settled on how it works or how reliably it affects sleep. Its research base centers on slow-wave brain activity and a broader role in neuroendocrine signaling, with human study results that have been mixed rather than consistent. It remains a peptide with genuine research history but no clearly established mechanism.

Frequently Asked Questions

What Does DSIP Stand For?

Delta Sleep-Inducing Peptide, named for its early association with delta wave activity, the brain signal pattern seen during deep sleep.

Where Was DSIP First Identified?

It was first isolated from the brain tissue of rabbits in the 1970s during a period of induced deep sleep.

Does DSIP Always Promote Sleep in Research Studies?

No. Results have varied depending on dose and timing, with some studies reporting increased sleep-related brain activity and others reporting the opposite. This inconsistency is a well-documented pattern in the DSIP literature.

Has DSIP Been Tested in Humans?

Yes, in a limited number of small studies, mostly involving people with chronic insomnia. Results across these studies have been mixed rather than consistently positive.

Sources and Research

  1. Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci U S A. 1977;74(3):1282-1286.
  2. Bes F, Hofman W, Schuur J, Van Boxtel C. Effects of Delta Sleep-Inducing Peptide on Sleep of Chronic Insomniac Patients: A Double-Blind Study. Neuropsychobiology. 1992;26(4):193-197.

Related Reading

For educational and research purposes only. Not medical advice. Always consult a licensed healthcare professional before starting any protocol.